Will Thermo Fisher (TMO) Beat Estimates Again in Its Next Earnings Report?

Looking for a stock that has consistently beaten earnings estimates and could be well-positioned to continue its streak into its next quarterly report? Thermo Fisher Scientific (TMO), which belongs to the Zacks Medical – Instruments industry, could be a great candidate to consider.

Looking at the last two reports, this maker of scientific instruments and laboratory supplies has seen a strong streak of beating earnings estimates. The company has beaten estimates by an average of 3.65% over the last two quarters.

For the last reported quarter, Thermo Fisher showed earnings of $2.62 per share, compared to the Zacks consensus estimate of $2.55 per share, representing a surprise of 2.75%. In the previous quarter, the company was expected to post earnings of $2.63 per share and actually came out at $2.75 per share, representing a surprise of 4.56%.

Price and EPS are surprising

In the case of Thermo Fisher, estimates are higher, thanks in part to this earnings surprise history. And when you look at the stock’s positive Zacks Earnings ESP (Expected Surprise Prediction), it’s a great indicator of future earnings beats, especially when paired with its solid Zacks Rank.

Our research shows that stocks with the combination of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better deliver a positive surprise almost 70% of the time. In other words, if you have 10 stocks with this combination, the number of stocks that beat consensus estimates could be as many as seven.

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a revision of the Zacks Consensus definition that is related to revision. The idea is that analysts revising their estimates just before an earnings release have the latest information, which could potentially be more accurate than what they and other contributors to the consensus had previously predicted.

Thermo Fisher currently has an Earnings ESP of +1.64%, suggesting that analysts have recently become bullish on the company’s earnings prospects. This positive Earnings ESP, combined with the stock’s Zacks Rank #3 (Hold), indicates that another beat is likely just around the corner. We expect the company’s next earnings report to be released on January 30, 2019.

When the Earnings ESP is negative, investors should remember that this will reduce the predictive power of the indicator. However, a negative value is not an indicator of a lack of earnings for the stock.

Many companies end up beating consensus EPS estimates, although that’s not the only reason their stocks appreciate. In addition, some stocks can remain stable even if they end up missing consensus estimates.

For this reason, it is very important to check a company’s Earnings ESP before its quarterly release to increase your chances of success. Make sure you use our Earnings ESP Filter to discover the best stocks to buy or sell before they are released.

Want the latest recommendations from Zacks Investment Research? Today you can download the 7 best stocks for the next 30 days. Click to get this free report

Thermo Fisher Scientific Inc. (TMO): Free Stock Analysis Report

To read this article on Zacks.com click here.